InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (5 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
5
T+90 hit rate
31%
T+90 mean return
+0.5%
Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by ASELAGE STEVE, Director. Officer active across 4 companies, notably Travere Therapeutics, Inc.. In total, 30 disclosures have been logged. Breakdown: 4 buys · 5 sells. Total volume traded: €2.3m. History available since 11 May 2021. The latest transaction was disclosed on 12 June 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations30 total
6,820 shares0Common StockSEC:0001127602-24-018708:0
2,500 shares@ US$6.4025.6% of flowCommon StockSEC:0001127602-24-016776:0
Ideal exit: 18 Feb 2025 (T+270)
483,741 sharesCommon Stock, $0.0001 par value per shareSEC:0000899243-23-020445:0
16,745 shares0Common StockSEC:0001127602-23-018786:0
409,836 shares@ US$1.2298.4% of flowCommon StockSEC:0001209191-22-059172:0
Ideal exit: 26 Aug 2023 (T+270)
12,866 shares0Common StockSEC:0001127602-22-017138:0
569 shares@ US$9.310.0003% mcap11.4% of flowCommon StockSEC:0001127602-22-016409:0
2,575 shares@ US$21.92490.0014% mcap1.4% of flowCommon StockSEC:0001209191-22-028702:0
301 shares@ US$16.610.0003% mcap10.4% of flowCommon StockSEC:0001127602-22-007717:0
2,016 shares@ US$2.15100.0% of flowCommon StockSEC:0001209191-21-069227
Ideal exit: 5 Sept 2022 (T+270)
2,016 shares@ US$2.1550.0% of flowCommon StockSEC:0001209191-21-069227:0
Ideal exit: 5 Sept 2022 (T+270)
414 shares@ US$12.060.0003% mcap10.3% of flowCommon StockSEC:0001127602-21-030063:0
414 shares@ US$12.060.0003% mcap26.2% of flowCommon StockSEC:0001127602-21-030063
31,800 shares@ US$29.390.021% mcap22.0% of flowCommon StockSEC:0001209191-21-065439:0
31,800 shares@ US$29.390.021% mcap44.7% of flowCommon StockSEC:0001209191-21-065439
10,000 shares@ US$16.230.0035% mcap3.8% of flowCommon StockSEC:0001209191-21-063591:0
10,000 shares@ US$16.230.0035% mcap7.6% of flowCommon StockSEC:0001209191-21-063591
25,000 shares0Common StockSEC:0001209191-21-062670
25,000 shares0Common StockSEC:0001209191-21-062670:0
60,000 shares@ US$16.230.021% mcap22.6% of flowCommon StockSEC:0001209191-21-060035:0
60,000 shares@ US$16.2322.6% of flowCommon StockSEC:0001209191-21-060035
314 shares@ US$15.920.0003% mcap9.8% of flowCommon StockSEC:0001127602-21-024772:0
314 shares@ US$15.927.3% of flowCommon StockSEC:0001127602-21-024772
634 shares@ US$15.7719.0% of flowCommon StockSEC:0001127602-21-018470
634 shares@ US$15.770.0005% mcap19.0% of flowCommon StockSEC:0001127602-21-018470:0
25 of 30 declarations
About ASELAGE STEVE
ASELAGE STEVE is an executive at Travere Therapeutics, Inc.
